OSCR - Oscar Health, Inc. Stock Price, Fair Value and News

22.43USD+0.28 (+1.26%)Delayed as of 17 May 2024, 09:56 am ET

Market Summary

USD22.43+0.28

Delayedas of 17 May 2024, 09:56 am

1.26%

OSCR Alerts

Big jump in Revenue (Y/Y)

Big jump in Earnings (Y/Y)

OSCR Stock Price

View Fullscreen

OSCR RSI Chart

OSCR Valuation

Market Cap

5.1B

Price/Earnings (Trailing)

-95.63

Price/Sales (Trailing)

0.78

EV/EBITDA

472.08

Price/Free Cashflow

-97.63

OSCR Price/Sales (Trailing)

OSCR Profitability

EBT Margin

-0.78%

Return on Equity

-5.18%

Return on Assets

-1.21%

Free Cashflow Yield

-1.02%

OSCR Fundamentals

OSCR Revenue

Revenue (TTM)

6.5B

Rev. Growth (Yr)

45.77%

Rev. Growth (Qtr)

49.64%

OSCR Earnings

Earnings (TTM)

-53.6M

Earnings Growth (Yr)

547.58%

Earnings Growth (Qtr)

218.12%

Breaking Down OSCR Revenue

52 Week Range

5.3122.46

(Low)(High)

Last 7 days

-0.1%

Last 30 days

41.3%

Last 90 days

24.7%

Trailing 12 Months

203.4%

How does OSCR drawdown profile look like?

OSCR Financial Health

Current Ratio

1.16

Debt/Equity

0.29

Debt/Cashflow

-0.18

OSCR Investor Care

Shares Dilution (1Y)

6.70%

Diluted EPS (TTM)

-0.42

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	6.5B	0	0	0
2023	4.5B	5.0B	5.4B	5.9B
2022	2.4B	2.9B	3.4B	4.0B
2021	1.9B	2.2B	2.4B	1.8B
2020	1.2B	1.4B	1.5B	1.7B
2019	0	0	0	1.0B

Get all data in R, Python etc through our Historical Stock Data APIs

Tracking the Latest Insider Buys and Sells of Oscar Health, Inc.

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Apr 03, 2024	bertolini mark t	acquired	-	-	955,555	chief executive officer
Mar 06, 2024	blackley richard scott	sold	-381,847	14.12	-27,043	chief financial officer
Mar 06, 2024	quane alessandrea c.	sold	-186,850	14.12	-13,233	evp, chief insurance officer
Mar 05, 2024	quane alessandrea c.	acquired	-	-	31,250	evp, chief insurance officer
Mar 05, 2024	blackley richard scott	acquired	-	-	62,500	chief financial officer
Mar 04, 2024	blackley richard scott	sold	-227,814	15.88	-14,346	chief financial officer
Mar 04, 2024	quane alessandrea c.	sold	-252,937	15.88	-15,928	evp, chief insurance officer
Mar 04, 2024	baltrus victoria	sold	-535,267	15.88	-33,707	chief accounting officer
Mar 04, 2024	bopitiya ranmali	sold	-181,445	15.88	-11,426	evp & chief legal officer
Mar 01, 2024	baltrus victoria	acquired	-	-	16,432	chief accounting officer

Which funds bought or sold OSCR recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
May 15, 2024	Point72 Asset Management, L.P.	sold off	-100	-18,343,300	-	-%
May 15, 2024	VK Services, LLC	sold off	-100	-62,666,400	-	-%
May 15, 2024	CITADEL ADVISORS LLC	reduced	-74.09	-15,305,800	11,131,000	-%
May 15, 2024	FARALLON CAPITAL MANAGEMENT LLC	new	-	163,570	163,570	-%
May 15, 2024	Tower Research Capital LLC (TRC)	reduced	-85.71	-269,743	81,562	-%
May 15, 2024	ALGERT GLOBAL LLC	added	17.14	1,091,000	2,299,000	0.09%
May 15, 2024	RBF Capital, LLC	unchanged	-	2,571,730	6,685,610	0.37%
May 15, 2024	JANUS HENDERSON GROUP PLC	added	0.09	329,874	855,102	-%
May 15, 2024	D. E. Shaw & Co., Inc.	reduced	-47.39	-774,737	4,564,960	-%
May 15, 2024	TWO SIGMA ADVISERS, LP	reduced	-17.76	5,667,570	22,507,200	0.05%

Are Funds Buying or Selling OSCR?

Are funds buying OSCR calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own OSCR

No. of Funds

Unveiling Oscar Health, Inc.'s Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 14, 2024	dragoneer investment group, llc	6.7%	12,725,999	SC 13G
Feb 14, 2024	general catalyst group management holdings gp, llc	1.1%	2,107,719	SC 13G/A
Feb 14, 2024	khosla ventures iv, l.p.	2.4%	4,564,404	SC 13G/A
Feb 13, 2024	vanguard group inc	7.47%	14,244,912	SC 13G/A
Feb 12, 2024	flynn james e	5.89%	11,246,820	SC 13G/A
Feb 02, 2024	capitalg 2015 lp	0.0%	0	SC 13G/A
Jan 26, 2024	blackrock inc.	7.5%	14,351,597	SC 13G/A
Jan 10, 2024	southeastern asset management inc/tn/	3.0%	571	SC 13G/A
Dec 01, 2023	flynn james e	5.52%	10,537,491	SC 13G
Feb 14, 2023	southeastern asset management inc/tn/	8.1%	145	SC 13G/A

Recent SEC filings of Oscar Health, Inc.

View All Filings

Date Filed	Form Type	Document
May 07, 2024	10-Q	Quarterly Report
May 07, 2024	3	Insider Trading
May 07, 2024	4	Insider Trading
May 07, 2024	8-K	Current Report
Apr 25, 2024	ARS	ARS
Apr 25, 2024	DEF 14A	DEF 14A
Apr 25, 2024	DEFA14A	DEFA14A
Apr 15, 2024	4	Insider Trading
Apr 05, 2024	4	Insider Trading
Mar 12, 2024	4	Insider Trading

Peers (Alternatives to Oscar Health, Inc.)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
UNH	479.9B	379.5B	11.20%	7.55%	31.24	1.26	12.96%	-25.81%
CI	96.4B	206.0B	-2.18%	28.90%	25.01	0.47	12.55%	-43.95%
HCA	84.6B	66.7B	2.85%	17.20%	15.46	1.27	9.59%	-4.59%
CVS	72.2B	360.9B	-16.66%	-17.14%	9.86	0.2	9.07%	78.49%
CNC	41.2B	155.5B	6.71%	14.75%	15.05	0.26	6.34%	84.42%
UHS	12.0B	14.7B	10.86%	33.14%	14.73	0.82	7.99%	19.23%
DVA	12.0B	12.3B	5.19%	38.43%	14.68	0.97	5.77%	58.74%
MID-CAP
CHE	8.6B	2.3B	-6.84%	5.15%	30.33	3.75	5.96%	18.29%
ACHC	6.2B	3.0B	-6.14%	-7.19%	-547.09	2.07	10.92%	-104.06%
AMEH	2.3B	1.5B	8.58%	22.04%	36.93	1.59	19.34%	40.15%
AMN	2.2B	3.5B	3.96%	-38.10%	15.61	0.64	-27.67%	-62.43%
SMALL-CAP
ADUS	1.8B	1.1B	13.47%	25.04%	27.49	1.66	11.45%	30.74%
BKD	1.4B	3.0B	11.90%	88.00%	-7.82	0.45	4.98%	4.88%
BEAT	55.6M	-	17.22%	-3.21%	-3.68	-	-	-1.05%
AMS	21.1M	21.6M	17.97%	25.63%	38.19	0.98	9.04%	-50.63%

Oscar Health, Inc. News

Latest updates

Oscar Health, Inc. Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

Income Statement (Quarterly)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4
Revenue	49.6%	2,142,305,000	1,431,658,000	1,439,991,000	1,521,535,000	1,469,685,000	995,127,000	978,427,000	1,017,319,000	972,765,000	823,112,500	673,460,000	723,927,000	610,099,000	439,846,000	414,505,000	393,540,000	424,448,000	-
S&GA Expenses	-100.0%	-	85,610,000	75,503,000	76,453,000	102,150,000	75,808,000	78,557,000	80,754,000	74,664,000	89,337,000	60,003,000	51,166,000	64,572,000	62,276,000	36,546,000	35,994,000	31,839,000	-
EBITDA Margin	102.8%	0.00	-0.04	-0.05	-0.09	-0.12	-0.14	-0.16	-0.20	-0.23	-0.30	-0.22	-0.19	-0.20	-0.23	-0.17	-0.19	-0.21	-0.24
Interest Expenses	-5.1%	5,902,000	6,217,000	6,130,000	6,120,000	6,136,000	6,135,000	6,126,000	6,141,000	4,221,000	397,000	398,000	228,000	3,697,000	3,514,000	-	-	-	-
Income Taxes	223.6%	996,000	-806,000	915,000	1,164,000	2,021,000	-715,000	-1,615,000	290,000	1,517,000	-111,000	-597,000	589,000	965,000	-481,000	-998,000	1,593,000	931,000	-
Earnings Before Taxes	218.5%	178,478,000	-150,644,000	-64,788,000	-14,261,000	-37,607,000	-227,275,000	-195,162,000	-111,835,000	-75,803,000	-197,852,000	-212,078,000	-72,734,000	-87,916,000	-190,351,000	-80,130,000	-39,351,000	-95,948,000	-
EBT Margin	82.8%	-0.01	-0.05	-0.06	-0.10	-0.13	-0.15	-0.17	-0.21	-0.24	-0.31	-0.23	-0.20	-0.21	-0.24	-0.17	-0.19	-0.22	-0.25
Net Income	218.1%	177,368,000	-150,153,500	-65,398,000	-15,425,000	-39,628,000	-224,981,500	-192,913,000	-112,125,000	-77,320,000	-198,921,000	-211,481,000	-73,323,000	-88,881,000	-189,870,000	-79,132,000	-40,944,000	-96,879,000	-
Net Income Margin	82.2%	-0.01	-0.05	-0.06	-0.10	-0.13	-0.15	-0.17	-0.21	-0.24	-0.31	-0.23	-0.20	-0.21	-0.24	-0.17	-0.19	-0.22	-0.25
Free Cashflow	113.7%	634,363,000	296,868,000	-1,149,266,000	165,524,000	414,715,000	151,394,000	-548,361,000	214,467,000	562,849,000	34,479,000	-589,252,000	55,337,000	317,691,000	88,983,000	-218,923,000	246,322,000	106,350,000	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet														(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4
Assets	22.7%	4,419	3,601	3,350	4,565	4,483	4,527	4,309	4,751	4,351	3,322	3,170	3,706	3,594	2,272
Current Assets	14.5%	3,504	3,061	2,992	4,193	4,131	4,122	3,931	4,260	3,675	2,306	2,241	2,816	3,179	1,870
Cash Equivalents	20.5%	2,253	1,870	1,400	2,322	2,110	1,559	2,113	2,363	2,069	1,104	1,077	1,672	2,321	843
Net PPE	-0.8%	61.00	62.00	62.00	63.00	64.00	60.00	56.00	51.00	49.00	47.00	43.00	41.00	39.00	36.00
Liabilities	21.1%	3,385	2,795	2,428	3,613	3,551	3,634	3,224	3,503	3,015	1,929	1,617	1,973	1,808	1,823
Current Liabilities	24.3%	3,019	2,429	2,061	3,244	3,182	3,264	2,853	3,130	2,641	1,852	1,617	1,973	1,808	1,666
Long Term Debt	0.1%	299	299	299	298	298	298	298	298	297	-	-	-	-	142
LT Debt, Non Current	-100.0%	-	299	299	298	298	298	298	298	297	-	-	-	-	142
Shareholder's Equity	28.6%	1,034	804	919	952	932	890	1,085	1,248	1,335	1,393	1,553	1,732	1,785	-
Retained Earnings	6.2%	-2,699	-2,876	-2,726	-2,661	-2,645	-2,605	-2,379	-2,187	-2,074	-1,999	-1,800	-1,587	-1,514	-1,427
Additional Paid-In Capital	1.5%	3,737	3,682	3,654	3,621	3,583	3,509	3,479	3,450	3,422	3,394	3,356	3,324	3,303	133
Shares Outstanding	4.4%	231	222	223	219	217	212	212	211	211	179	169	207	89.00	29.00
Minority Interest	5.3%	2.00	2.00	2.00	2.00	2.00	2.00	3.00	3.00	3.00	5.00	-	-	-	-
Float	-	-	-	-	1,500	-	-	-	728	-	-	-	3,386	-	-

Cashflow (Last 12 Months)

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Cashflow (Quarterly)																		(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4
Cashflow From Operations	113.7%	634	297	-1,149	166	415	151	-548	214	563	34.00	-589	55.00	318	89.00	-218	246	106	-
Share Based Compensation	-0.8%	26.00	26.00	29.00	33.00	71.00	29.00	29.00	27.00	28.00	28.00	21.00	18.00	19.00	14.00	7.00	7.00	8.00	-
Cashflow From Investing	-274.3%	-300	172	225	44.00	136	-706	299	79.00	103	-19.84	-12.36	-708	-34.28	15.00	-433	26.00	48.00	-
Cashflow From Financing	2454.6%	27.00	1.00	2.00	3.00	1.00	1.00	0.00	1.00	299	13.00	11.00	3.00	1,212	385	1.00	225	0.00	-

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

OSCR Income Statement

2024-03-31

Condensed Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Revenue
Premium	$ 2,093,682	$ 1,428,626
Investment income	42,989	36,056
Services and other	5,634	5,003
Total revenue	2,142,305	1,469,685
Operating Expenses
Medical	1,554,774	1,091,592
Selling, General and Administrative Expense	394,162	398,519
Depreciation and amortization	7,811	4,939
Total operating expenses	1,956,747	1,495,050
Earnings (loss) from operations	185,558	(25,365)
Interest expense	5,902	6,136
Other expenses	1,178	6,106
Earnings (loss) before income taxes	178,478	(37,607)
Income tax expense	996	2,021
Net income (loss)	177,482	(39,628)
Less: Net income attributable to noncontrolling interests	114	144
Net income (loss) attributable to Oscar Health, Inc.	$ 177,368	$ (39,772)
Earnings (Loss) per Share
Basic (in dollars per share)	$ 0.77	$ (0.18)
Diluted (in dollars per share)	$ 0.62	$ (0.18)
Weighted average common shares outstanding, basic (in shares)	231,443,000	216,913,000
Weighted-average common shares outstanding, diluted (in shares)	293,796,000	216,913,000

OSCR Balance Sheet

2024-03-31

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Current Assets:
Cash and cash equivalents	$ 2,230,799	$ 1,870,315
Short-term investments	616,134	689,833
Premiums and accounts receivable (net of allowance for credit losses of $30,600 and $31,600)	342,904	201,269
Risk adjustment transfer receivable	62,037	51,925
Reinsurance recoverable	242,935	241,194
Other current assets	8,983	6,564
Total current assets	3,503,792	3,061,100
Property, equipment, and capitalized software, net	61,406	61,930
Long-term investments	736,624	365,309
Restricted deposits	29,814	29,870
Other assets	87,217	83,271
Total assets	4,418,853	3,601,480
Current Liabilities:
Benefits payable	1,248,347	965,986
Risk adjustment transfer payable	1,336,022	1,056,941
Premium deficiency reserve	4,332	5,776
Unearned premiums	65,541	65,918
Accounts payable and other liabilities	303,245	273,367
Reinsurance payable	61,938	61,024
Total current liabilities	3,019,425	2,429,012
Long-term debt	298,972	298,777
Other liabilities	66,169	67,574
Total liabilities	3,384,566	2,795,363
Commitments and contingencies (Note 12)
Stockholders' Equity
Treasury stock (315 thousand shares as of March 31, 2024 and December 31, 2023)	(2,923)	(2,923)
Additional paid-in capital	3,736,885	3,682,294
Accumulated deficit	(2,699,347)	(2,876,715)
Accumulated other comprehensive income (loss)	(2,594)	1,309
Total Oscar Health, Inc. stockholders' equity	1,032,023	803,967
Noncontrolling interests	2,264	2,150
Total stockholders' equity	1,034,287	806,117
Total liabilities and stockholders' equity	4,418,853	3,601,480
Class A
Stockholders' Equity
Common stock	2	2
Class B
Stockholders' Equity
Common stock	$ 0	$ 0

About Oscar Health, Inc.

Oscar Health, Inc. operates as a health insurance in the United States. The company offers Individual and Small Group, and Medicare Advantage plans, as well as +Oscar, a technology driven platform designed to help providers and payors directly enable their shift to value-based care It also provides reinsurance products. The company was formerly known as Mulberry Health Inc. and changed its name to Oscar Health, Inc. in January 2021. Oscar Health, Inc. was incorporated in 2012 and is headquartered in New York, New York.

CEO	Mr. Mark Thomas Bertolini
WEBSITE	hioscar.com
INDUSTRY	Healthcare Plans
EMPLOYEES	2714

Oscar Health, Inc. Frequently Asked Questions

What is the ticker symbol for Oscar Health, Inc.? What does OSCR stand for in stocks?

OSCR is the stock ticker symbol of Oscar Health, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Oscar Health, Inc. (OSCR)?

As of Thu May 16 2024, market cap of Oscar Health, Inc. is 5.13 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of OSCR stock?

You can check OSCR's fair value in chart for subscribers.

What is the fair value of OSCR stock?

You can check OSCR's fair value in chart for subscribers. The fair value of Oscar Health, Inc. is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Oscar Health, Inc. is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for OSCR so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Oscar Health, Inc. a good stock to buy?

The fair value guage provides a quick view whether OSCR is over valued or under valued. Whether Oscar Health, Inc. is cheap or expensive depends on the assumptions which impact Oscar Health, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for OSCR.

What is Oscar Health, Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Thu May 16 2024, OSCR's PE ratio (Price to Earnings) is -95.63 and Price to Sales (PS) ratio is 0.78. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. OSCR PE ratio will change depending on the future growth rate expectations of investors.